Your browser doesn't support javascript.
loading
COVID-19 and the risk of CNS demyelinating diseases: A systematic review.
Lotan, Itay; Nishiyama, Shuhei; Manzano, Giovanna S; Lydston, Melissa; Levy, Michael.
Afiliación
  • Lotan I; Division of Neuroimmunology and Neuroinfectious Disease, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
  • Nishiyama S; Division of Neuroimmunology and Neuroinfectious Disease, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
  • Manzano GS; Division of Neuroimmunology and Neuroinfectious Disease, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
  • Lydston M; Treadwell Virtual Library for the Massachusetts General Hospital, Boston, MA, United States.
  • Levy M; Division of Neuroimmunology and Neuroinfectious Disease, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Front Neurol ; 13: 970383, 2022.
Article en En | MEDLINE | ID: mdl-36203986
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Guideline / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Front Neurol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Guideline / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Front Neurol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos